- Pluxee reported second-quarter revenue of EU346 million.
- The company projects Float revenue to increase by mid-to-high single digits in Fiscal 2025, informed by current forward curves.
- Pluxee has upgraded its objective for the Recurring EBITDA margin for Fiscal 2025, indicating strong performance in the first semester.
- The company maintains its organic total revenue growth and recurring cash conversion objectives for the full year, despite macro-economic uncertainties.
- Analyst ratings for Pluxee include 7 buy recommendations, 9 holds, and 1 sell.
“`
A look at Pluxee Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 5 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Pluxee N.V., a provider of employee benefits and motivation solutions globally, shows a promising long-term outlook based on Smartkarma Smart Scores. With a strong emphasis on growth and resilience, Pluxee‘s future looks optimistic as it continues to expand its offerings in catering, well-being, mobility, culture, and gifts. While the company scores moderately on value, dividend, and momentum factors, its high scores in growth and resilience indicate a robust foundation for sustained success in the employee benefits industry.
Pluxee‘s focus on enhancing employee experiences and boosting motivation aligns well with its top scores in resilience and growth. These scores suggest that the company is well-positioned to navigate challenges and capitalize on opportunities in the market. With a diversified range of services catering to a global clientele, Pluxee‘s strategic approach to employee benefits underscores its potential for long-term growth and stability.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
